Diabetes and Bone – New developments and the important role of sclerostin signalling, 2 March

Presented by Professor Lorenz C Hofbauer, University Medical Centre at Technical University Dresden

9.30-10.30am, Friday 2 March, MMC Surgery Seminar Room, Block E, Level 5

Professor Hofbauer studied medicine at the University of Munich and obtained his MD degree 1995 in the thyroid field. His interest in bone research was stimulated during a post-doctoral fellowship at the Mayo Clinic, Rochester, MN, USA under the mentorship of Drs. Larry Riggs and Sundeep Khosla from 1996 to 1999.

In 1999, Professor Hofbauer moved to Philipps-University of Marburg, Germany, where he established his own research group focusing on the RANKL/OPG biology in skeletal, malignant, and vascular diseases. In parallel, Professor Hofbauer completed his clinical education in internal medicine, endocrinology, and diabetes with board exams in 2003 and 2004. From 2004 to 2007 he was a DFG Heisenberg senior fellow and consultant in medicine.

In 2007, Professor Hofbauer became Head of the Division of Endocrinology, Diabetes, and Bone Diseases, Department of Medicine III at the University Medical Center at Technische Universität, Dresden, Germany having also completed subspecialty training and board certification in gastroenterology and geriatrics.

Since 2011, Professor Hofbauer obtained funding for DFG-Forschergruppe SKELMET on the pathogenesis of bone metastases, which entered into the second funding period in 2014.

In 2016, he was appointed Director of the Center for Healthy Aging at the Dresden University Medical Center with an interdisciplinary medical and scientific focus on maintaining lifelong mobility and autonomy. In 2018, he became Deputy Editor of the Journal of Bone and Mineral Research, the Journal with the highest impact factor in the discipline of bone and mineral disorders.